ASML Reports Weaker Than Expected First-Quarter Bookings, China Sales Hold Up

ASML, the largest supplier of equipment to computer chip makers, reported weaker than expected first-quarter new bookings on Wednesday, causing shares in Europe’s biggest tech firm to drop 4.5% to 873.40 euros at 0741 GMT. Despite this setback, sales to China remained strong, defying U.S.-led restrictions.

The Dutch group is experiencing a temporary slowdown in demand for its most advanced machines but is anticipating robust growth in 2025 due to the increasing demand for AI and memory chips. ASML is set to benefit from new chip plants planned with government support in various countries.

Although first-quarter new bookings were below analysts’ expectations at 3.6 billion euros, ASML remains optimistic about the future. Sales to customers in China accounted for a record 49% of total sales in the first quarter, highlighting the company’s strong presence in the region.

The U.S. government’s restrictions on exports of advanced chipmaking equipment to China have led Chinese chipmakers to seek older ASML equipment that is not subject to these restrictions. This trend, combined with the overall growth in chipmaking capacity in China, Taiwan, and South Korea, bodes well for ASML’s future prospects.

Despite the weaker bookings, outgoing CEO Wennink expressed confidence in a stronger second half of the year and described 2024 as a “transition year.” Investors like Han Dieperink from Aureus remain optimistic about ASML’s long-term growth outlook, citing the company’s position as a key player in the AI and memory chip markets.

ASML’s first-quarter net income was 1.22 billion euros, with sales totaling 5.29 billion euros. The company’s financial forecasts for 2024 remain unchanged, with sales expected to be flat compared to 2023.

With a new CEO set to take over at the upcoming annual meeting, ASML is poised to navigate the challenges of the industry and capitalize on the growing demand for advanced chip technology.

Surecomp Announces Strategic Partnership with Cleareye.ai for Digital Trade Finance Solutions

Surecomp® and Cleareye.ai Inc. Join Forces to Revolutionize Trade Finance

In a move to address the challenges faced by financial institutions engaged in cross-border trade, Surecomp® has announced a strategic partnership with Cleareye.ai Inc., a leading provider of digital trade finance solutions. The collaboration aims to streamline trade compliance and operations through the use of advanced technology.

The platform leverages technology breakthroughs with a fully automated document processing layer, unified ML lifecycle management, data management, model governance, and dynamic rules engine leveraging NLP. This innovative approach will provide financial institutions with a comprehensive solution to enhance trade productivity and speed while reducing risks and ensuring compliance.

Sarath Sasikumar, President & Co-Founder of Cleareye.ai, expressed excitement about the partnership, stating, “By combining our expertise with Surecomp, we can provide financial institutions with a powerful and comprehensive solution that empowers them to navigate the complexities of trade finance with greater efficiency and confidence.”

Enno-Burghard Weitzel, Surecomp’s Chief Solutions Officer, highlighted the importance of AI-based compliance checks in trade finance transactions, stating, “Banks continuously need to stay ahead of the ever-changing patterns in illegal trade behavior. Embedding AI-based compliance checks into the trade finance transaction is a prime use case for bringing artificial intelligence to banks’ day-to-day operations.”

Overall, the partnership between Surecomp and Cleareye represents a significant step forward in revolutionizing trade finance and empowering financial institutions to manage growing volumes of trade efficiently. With a focus on automation and compliance, this collaboration is set to transform the way banks approach cross-border trade.

ASML Holding NV Falls Short of Analyst Expectations Amid Chip Industry Downturn

ASML Holding NV, the world’s sole producer of equipment needed to make the most advanced chips, is facing a downturn in demand for its top-end extreme ultraviolet machines. The company posted new orders of €3.6 billion in the first quarter, falling short of analyst expectations of €4.63 billion. This decline in orders has caused ASML shares to drop by 7.3% on Tradegate.

The slump in demand for ASML’s most advanced machines is a result of weaker-than-expected sales in the chip making industry. Orders for extreme ultraviolet machines plunged to €656 million in the first quarter from €5.6 billion in the previous quarter. The company is expecting sales to remain weak in the second quarter before demand starts to pick up.

Despite the current challenges, ASML’s Chief Executive Officer, Peter Wennink, remains optimistic about the company’s outlook for the full year 2024. He expects the second half of the year to be stronger than the first half, in line with the industry’s continued recovery from the downturn.

ASML sees sales in the current quarter between €5.7 billion and €6.2 billion, missing estimates of €6.5 billion before demand picks up. The company’s Chief Financial Officer, Roger Dassen, believes that the industry is in an upturn and anticipates a stronger year in 2025.

While ASML’s business in Taiwan and the US has been affected by the downturn, its China business has remained relatively resilient. However, new export control measures have restricted ASML from selling certain equipment to China, affecting up to 15% of its sales in the country.

ASML’s chief business officer, Christophe Fouquet, will take over as CEO when Wennink retires later this month. He will have to navigate geopolitical pressures from the US while satisfying shareholders accustomed to growth. Despite the current challenges, ASML’s biggest customers, like Taiwan Semiconductor Manufacturing Co., have been posting positive results, indicating a potential turnaround in the industry.

Overall, ASML remains optimistic about the future, expecting a recovery in demand and sales in the coming quarters as the industry continues to recover from the downturn.

Idorsia Pharmaceuticals Ltd Announces Unaudited Financial Status and Bondholder Meeting Update

Idorsia Pharmaceuticals Ltd, a leading biopharmaceutical company headquartered near Basel, Switzerland, has recently made an ad hoc announcement regarding its Unaudited Financial Status as of March 31, 2024. This information is crucial for an upcoming bondholder meeting, which is now planned for early May.

The company, listed on the SIX Swiss Exchange, is currently engaging with bondholders to discuss options and terms regarding the repayment of a convertible bond maturing on July 17, 2024. As a result of these ongoing discussions, the bondholder meeting, initially scheduled for April 30, 2024, will be postponed to a later date.

André C. Muller, Chief Financial Officer of Idorsia, stated, “We have had many interactions with our bondholders in the past week. We are finalizing our proposed amendment to the terms and conditions of the bond, taking into account the bondholder needs as well as our objective to avoid unnecessary dilution. We expect to publish the invitation to the bondholders meeting in the next few days.”

Idorsia is dedicated to developing innovative drugs and transforming the horizon of therapeutic options for patients. With a strong scientific core and a broad portfolio of drugs in the pipeline, the company aims to become a leading player in the biopharmaceutical industry.

For further information, interested parties can contact Andrew C. Weiss, Senior Vice President, Head of Investor Relations & Corporate Communications at Idorsia Pharmaceuticals Ltd. The company’s contact information can be found on their website.

The company’s forward-looking statements reflect their current views and plans for the future, but are subject to certain risks and uncertainties. Despite these challenges, Idorsia remains committed to realizing its ambitious targets and bringing innovative medicines to patients worldwide.